恆指吐近300點 百威亞太(01876.HK)回吐半成
港股繼昨天3月開局由近兩個月低位呈報復性勁彈833點或4.2%收復2月累瀉逾二千點部分失地後,恆指今早低開229點或1.1%報20,390,在科指跌幅擴至2.1%至4,097拖累,跌幅擴至298點或1.4%,報20,321,總成交額176億元。
藍籌股普遍回吐,尤其是全年少賺4%百威亞太(01876.HK)今早股價重失50天線(24.5元),最多跌6%低見23.65元,現報23.9元,回吐半成,成交201萬股。
百威亞太去年純利按年倒退3.9%至9.13億美元(下同),每股盈利6.91仙,末期股息按年增25%至3.78仙。期內,營業額按年減少4.6%至64.78億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.